Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.
about
Clinical implications of the molecular genetics of chronic lymphocytic leukemiaThe biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemiaIntegrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemiaThe role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia.Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma.Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we goAcquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants.The genomic landscape of chronic lymphocytic leukemia: clinical implications.State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia.A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia.Incidence and clinical implications of ATM aberrations in chronic lymphocytic leukemia.Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments.Toward personalized therapy for chronic lymphocytic leukemia: DSC and cDNA microarray assessment of two cases.Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes.Genomic approaches to chronic lymphocytic leukemia.Characteristics of chronic lymphocytic leukemia with somatically acquired mutations in NOTCH1 exon 34Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia.Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia.Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemiaIntegrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemiaGenetic Variation Associated with Longer Telomere Length Increases Risk of Chronic Lymphocytic LeukemiaPatients' Preferences for Genomic Diagnostic Testing in Chronic Lymphocytic Leukaemia: A Discrete Choice ExperimentIdentification of prognostic relevant chromosomal abnormalities in chronic lymphocytic leukemia using microarray-based genomic profiling.Multiple productive immunoglobulin heavy chain gene rearrangements in chronic lymphocytic leukemia are mostly derived from independent clonesClinical application of targeted and genome-wide technologies: can we predict treatment responses in chronic lymphocytic leukemia?Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness.Whole genome profiling and other high throughput technologies in lymphoid neoplasms--current contributions and future hopes.Paradigm shifts in the management of poor-risk chronic lymphocytic leukemia.The genomic landscape of chronic lymphocytic leukaemia: biological and clinical implications.Aberrant levels of SUV39H1 and SUV39H2 methyltransferase are associated with genomic instability in chronic lymphocytic leukemia.Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia.The molecular pathogenesis of chronic lymphocytic leukaemia.SNP Array in Hematopoietic Neoplasms: A Review.Waldenstrom Macroglobulinemia: Genomic Aberrations and Treatment.State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenografts.Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness AnalysisCell-Intrinsic Determinants of Ibrutinib-Induced Apoptosis in Chronic Lymphocytic Leukemia.Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption.
P2860
Q26830955-36D65AA0-19F1-4B1C-A3AE-D7513CBF70A1Q27024411-635E03D4-C58E-40F5-90F3-B55729A3D7A1Q28394721-586A5E6F-7C0C-4F3F-9E09-2CBB934F7132Q33409459-4AD69704-8DA8-46A6-89E8-CFBA75358866Q33567169-4BBF8972-A5E6-4B39-9F87-231EA7816B89Q33744997-E4F8CF18-5AC4-4C85-B073-83FE5462C503Q33818637-F60A5328-2923-4DC6-B4C2-EA468A225144Q34710882-9331A34B-04F7-4408-83E0-1AD0C3E27A7FQ35860550-E9290C03-3720-40DC-92CA-32534975F114Q35984259-99787175-14A1-43E7-9A26-77520EB81AE3Q36301081-7FF880A8-328E-4D97-AAFC-1ED038F9DF8FQ36421804-2B62689C-A64F-4A76-B7E6-FC8569B87293Q36520447-5422B99F-77C3-424E-B8F3-004B95D4F662Q36591941-24CFEE31-42A3-4E60-85A3-846A0EF6067BQ36651908-4FCC2FF7-3757-41C3-B6B7-B69BD8AC324EQ36737322-703826D3-8CB2-4473-A431-B03361ECF784Q36790673-44E2C0F0-00D6-446F-8815-1C482E808922Q36799831-5841608D-E0A8-406D-A124-6475C86A4DE8Q36842838-9759E91B-FA5A-456D-84CF-D7D207CB91E2Q36906625-7498B4C7-9734-4610-84C7-6898AC01AEEDQ37037294-92568D88-A4FD-4BDF-847B-0CCD0224B0BDQ37225819-6E9AA0A0-17FF-49F4-BE2A-92A6B1CE11A7Q37410709-04E27944-35C3-498D-9F6B-0BEEAD642912Q37528942-EBF2CD0F-60B9-4F54-B423-B8995D152C28Q37552043-22A341F2-4508-4385-9967-055D7E69B0C0Q37618663-A3A6451B-DC77-4EEE-88D6-33F8F339A20FQ37697850-7EA1D972-C483-4024-962F-09EE4C99E52CQ38071077-3CEF97FC-FD3D-4472-B898-7F0C78ADA43DQ38259446-0D946737-6334-4781-9191-4A3F9BC55E5BQ38286344-04A039E0-BDF2-440C-80F2-0512A68104C3Q38612097-E20AE25A-1903-4C10-BB7D-63DF593C702EQ38744632-9C02F9E5-B899-452A-B597-5606A80F0FF5Q38748645-D72C3B02-F185-4BA9-B7BE-BBEDDEC7322BQ38947537-274838FD-4B4B-49E7-BDAA-8E50B1B09CE4Q38970612-89B4AAC0-B173-4CF8-A931-31F7332D8AB7Q39085428-804A5C98-228C-4F07-B484-70CB76FBBD39Q41280348-A4F6D4D3-73B0-4207-89F8-DCA0E286C1DCQ41310328-A3A72549-52E8-4B29-9FDA-0765C6FE322EQ41848521-E1F52AB6-48EA-4FF9-991A-3761A1BF9334Q42537560-5EED8D8D-897B-4C94-9AA4-4BF157BE7F2B
P2860
Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.
@ast
Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.
@en
type
label
Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.
@ast
Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.
@en
prefLabel
Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.
@ast
Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.
@en
P2093
P2860
P1433
P1476
Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.
@en
P2093
Edward Peres
Jinghui Li
Kerby Shedden
Lisa Kujawski
Mark Kaminski
Moshe Talpaz
Peter Ouillette
Roxane Collins
Sajid Shakhan
P2860
P304
P356
10.1182/BLOOD-2010-12-327858
P407
P577
2011-07-27T00:00:00Z